Content reviewed by clinical research staff
Evidence graded using the PeptideScholar A-D system.
Elamipretide (SS-31) is a first-in-class mitochondria-targeted tetrapeptide that binds to cardiolipin in the inner mitochondrial membrane. It was granted FDA Breakthrough Therapy designation for Barth syndrome and is the first cardiolipin-directed therapeutic to reach late-stage clinical trials. It stabilizes mitochondrial structure and improves ATP production.
Selectively accumulates in mitochondria via its dimethyltyrosine residue and binds to cardiolipin, a phospholipid essential for inner mitochondrial membrane integrity. This binding prevents cardiolipin peroxidation, stabilizes respiratory supercomplexes, maintains cristae structure, and improves electron transport chain efficiency — ultimately enhancing ATP synthesis and reducing reactive oxygen species production.
This content is for informational purposes only and does not constitute medical advice.
The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.
SS-31 (Elamipretide) is not FDA-approved. Always consult a licensed healthcare provider before considering any peptide.
Get the Provider ChecklistStart with the evidence and provider checklist while routing is offline.
Neurology, 2023
Elamipretide did not meet primary endpoint in MMPOWER-3 for mitochondrial myopathy, but post-hoc analyses suggested benefit in specific genetic subgroups and biomarkers
The Peptide Protocols Handbook
Evidence-based reference guide covering mechanisms, research, and clinical applications.
View on AmazonThird-Party Peptide Testing
Independent lab analysis to verify peptide purity and authenticity.
Learn MoreLinks may be affiliate links. See our disclosure.
Equipment for responsible research-grade peptide handling and administration.
Alcohol Prep Pads (200 ct)
Sterile 70% isopropyl pads for injection site preparation — essential for subcutaneous protocols.
1mL Insulin Syringes (28G)
Thin-gauge 28G syringes for subcutaneous peptide administration with minimal discomfort.
Sharps Disposal Container (1 Qt)
Biohazard-safe sharps container for responsible disposal of used syringes.
Digital Milligram Scale (0.001g)
High-precision scale for accurate measurement of peptide powder before reconstitution.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Books covering peptide science, longevity research, and biohacking frameworks.
The Peptide Protocols
Comprehensive reference for peptide mechanisms, dosing research, and clinical applications.
Boundless by Ben Greenfield
Covers peptides, nootropics, hormones, and longevity strategies in an optimization framework.
Lifespan by David Sinclair
Evidence-based deep-dive into aging science, directly relevant to longevity peptide research.
The Longevity Paradox
Gut-centric aging research with diet and supplementation protocols for extending healthspan.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.